Greater aortic stiffness with Ex(9‐39) aligns with data from our previous study in humans with T2D, where we demonstrated that a GLP‐1 receptor agonist (exenatide) decreases aortic stiffness (Scalzo et al. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.